Bruker Corporation  

(Public, NASDAQ:BRKR)   Watch this stock  
Find more results for BRKR
26.96
+0.34 (1.28%)
Real-time:   10:42AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 26.71 - 27.01
52 week 19.58 - 27.85
Open 26.72
Vol / Avg. 52,111.00/660,424.00
Mkt cap 4.38B
P/E 28.65
Div/yield 0.04/0.59
EPS 0.94
Shares 159.94M
Beta 0.95
Inst. own 67%
Jul 31, 2017
Q2 2017 Bruker Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 22, 2017
Bruker Corp Annual Shareholders Meeting
May 4, 2017
Bruker Corp at Deutsche Bank Health Care Conference - Webcast
May 3, 2017
Q1 2017 Bruker Corp Earnings Call - Webcast
May 3, 2017
Q1 2017 Bruker Corp Earnings Release
Mar 15, 2017
Bruker Corp at Barclays Global Healthcare Conference
Mar 6, 2017
Bruker Corp at Cowen Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin 5.64% 9.59%
Operating margin 9.77% 11.57%
EBITD margin - 15.97%
Return on average assets 4.77% 8.73%
Return on average equity 12.28% 21.75%
Employees 6,000 -
CDP Score - -

Address

40 MANNING RD
BILLERICA, MA 01821
United States - Map
+1-978-6633660 (Phone)
+1-978-6635585 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions that enable its customers to explore life and materials at microscopic, molecular and cellular levels. The Company's segments include Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). The Company's products address the evolving needs of an array of customers in life science research, pharmaceuticals, biotechnology and applied markets, among others. Within BSI, the Company is organized into three segments: the Bruker BioSpin Group, the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group and the Bruker Nano Group. BEST designs, manufactures and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications.

Officers and directors

Frank H. Laukien Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Anthony L. Mattacchione Chief Financial Officer, Senior Vice President
Age: 54
Bio & Compensation  - Reuters
Juergen Srega President of Bruker CALID Group and Bruker Daltonics Division
Age: 62
Bio & Compensation  - Reuters
Mark Robert Munch Ph.D. Executive Vice President - President of Bruker Nano Group and Bruker Nano Surfaces Division
Age: 55
Bio & Compensation  - Reuters
William A. Linton Lead Independent Director
Age: 69
Bio & Compensation  - Reuters
Joerg C. Laukien Director
Age: 63
Bio & Compensation  - Reuters
Stephen W. Fesik Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters
Cynthia M. Friend Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters
Marc A. Kastner Ph.D. Independent Director
Age: 71
Bio & Compensation  - Reuters